[ultimate_modal icon_type=”custom” icon_img=”id^4832|url^https://www.carevive.com/wp-content/uploads/2017/07/ethan_basch.jpg|caption^null|alt^Ethan Basch, MD|title^Ethan Basch, MD|description^Ethan Basch, MD” modal_on=”image” btn_img=”id^4832|url^https://www.carevive.com/wp-content/uploads/2017/07/ethan_basch.jpg|caption^null|alt^Ethan Basch, MD|title^Ethan Basch, MD|description^Ethan Basch, MD” modal_size=”medium” modal_style=”overlay-fade” overlay_bg_opacity=”93″ content_bg_color=”#efefef” header_bg_color=”#efefef” modal_border_style=”solid” modal_border_width=”1″ modal_border_color=”#24a1c0″ modal_border_radius=”5″ img_size=”24″ img_close_background_color=”#24a1c0″ close_icon_position=”popup-edge-top-right” content_text_color=”#545454″ header_font_size=”desktop:20px;” header_line_height=”desktop:24px;” content_font_size=”desktop:18px;” content_line_height=”desktop:20px;”]Ethan Basch, MD

Ethan Basch, MD, MSc, FASCO is a medical oncologist and distinguished professor in the UNC School of Medicine Division of Hematology/Oncology and a professor in the UNC Gillings School of Global Public Health. He also is director of UNC Lineberger’s cancer outcomes research program. He was also recently elected to the American Society of Clinical Oncology (ASCO) Board of Directors.

He is a member of the Board of Scientific Advisors of the National Cancer Institute, a federally appointed member of the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI), Co-Chair of the Cancer Care Delivery Research Committee of the Alliance for Clinical Trials in Oncology, and Associate Editor of the Journal of the American Medical Association (JAMA).  He has led multiple national guidelines and clinical trials in prostate cancer and has pioneered research on patient self-reporting of symptoms during cancer treatment.[/ultimate_modal]

Ethan Basch, MD, MSc, FASCO

UNC-Chapel Hill
Director, Scientific Advisory Board

[ultimate_modal icon_type=”custom” modal_on=”image” btn_img=”id^8448|url^https://www.carevive.com/wp-content/uploads/2019/02/Doris_Howell_1-e1549341126484.jpg|caption^null|alt^Doris Howell RN, PhD|title^Doris Howell RN, PhD|description^Doris Howell
RN, PhD” modal_size=”medium” modal_style=”overlay-fade” overlay_bg_opacity=”93″ content_bg_color=”#efefef” header_bg_color=”#efefef” modal_border_style=”solid” modal_border_width=”1″ modal_border_color=”#24a1c0″ modal_border_radius=”5″ img_size=”24″ img_close_background_color=”#24a1c0″ close_icon_position=”popup-edge-top-right” content_text_color=”#545454″ header_font_size=”desktop:20px;” header_line_height=”desktop:24px;” content_font_size=”desktop:18px;” content_line_height=”desktop:20px;”]Doris Howell RN, PhD

Dr. Doris Howell has an extensive clinical background in cancer care. As a researcher, her main goal is to optimize the quality of cancer care and empower patients as co-producers of health and well-being. At U of T Nursing, Dr. Howell developed the Clinical Nursing Stream – Oncology curriculum in the master’s program.

Her clinical research aims to understand the role of a patient’s central perception and evaluation of complex symptoms – such as fatigue, pain and breathlessness – on symptom response and behaviour to inform the development of theory and behavioural self-management intervention trials.

Dr. Howell holds the RBC Chair, Oncology Nursing Research and Education, University Health Network. She is a Senior Scientist with the Princess Margaret Cancer Centre,  University Health Network. She is an Adjunct Scientist, Division of Preventive Oncology, Cancer Care Ontario;  and an Adjunct Scientist with the Institute for Clinical Evaluative Sciences.  Dr. Howell is cross-appointed to U of T’s Dalla Lana School of Public Health and its Department of Health Policy, Management and Evaluation within the Faculty of Medicine.[/ultimate_modal]

Doris Howell, RN, PhD

Princess Margaret Cancer Centre

[ultimate_modal icon_type=”custom” icon_img=”id^6600|url^https://www.carevive.com/wp-content/uploads/2018/08/pic_alberto_montero.jpeg|caption^null|alt^Alberto Montero, MD|title^Alberto Montero, MD|description^Alberto Montero, MD” modal_on=”image” btn_img=”id^6600|url^https://www.carevive.com/wp-content/uploads/2018/08/pic_alberto_montero.jpeg|caption^null|alt^Alberto Montero, MD|title^Alberto Montero, MD|description^Alberto Montero, MD” modal_size=”medium” modal_style=”overlay-fade” overlay_bg_opacity=”93″ content_bg_color=”#efefef” header_bg_color=”#efefef” modal_border_style=”solid” modal_border_width=”1″ modal_border_color=”#24a1c0″ modal_border_radius=”5″ img_size=”24″ img_close_background_color=”#24a1c0″ close_icon_position=”popup-edge-top-right” content_text_color=”#545454″ header_font_size=”desktop:20px;” header_line_height=”desktop:24px;” content_font_size=”desktop:18px;” content_line_height=”desktop:20px;”]Alberto Montero, MD

Dr.  Alberto Montero is a staff physician and the quality improvement officer at the Cleveland Clinic Taussig Cancer Institute. He is also an Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. His clinical work focuses on breast cancer.   Prior to joining the Cleveland Clinic, Dr. Montero was breast cancer site disease co-leader at the University of Miami Sylvester Comprehensive Cancer Center. Dr. Montero earned his medical degree from the University of Texas Medical Branch at Galveston, after which he completed a residency in internal medicine on the physician-scientist track at the University of Texas Houston Health Science Center. He then completed his fellowship training in hematology/oncology at the University of Texas M.D. Anderson Cancer Center. Dr. Montero’s research interests include improvement of clinical outcomes in patients with breast cancer through the development of novel targeted therapies.

He has been the principal investigator in over 30 clinical trials and has co-authored over 70 peer-reviewed publications.  Dr. Montero has also published several studies examining the cost-effectiveness of several targeted therapies currently utilized for the treatment of metastatic breast cancer.

Watch Dr. Montero: “Introduction to MACRA and the Future of Value-Based Care” [/ultimate_modal]

Alberto Montero, MD, MBA, CPHQ

Cleveland Clinic Taussig Cancer Institute

[ultimate_modal icon_type=”custom” icon_img=”id^1488|url^https://www.carevive.com/wp-content/uploads/2015/04/pic_deb_mayer.jpg|caption^null|alt^Deborah K. Mayer|title^Deborah K. Mayer|description^null” modal_on=”image” btn_img=”id^1488|url^https://www.carevive.com/wp-content/uploads/2015/04/pic_deb_mayer.jpg|caption^null|alt^Deborah K. Mayer|title^Deborah K. Mayer|description^null” modal_size=”medium” modal_style=”overlay-fade” overlay_bg_opacity=”93″ content_bg_color=”#efefef” header_bg_color=”#efefef” modal_border_style=”solid” modal_border_width=”1″ modal_border_color=”#24a1c0″ modal_border_radius=”5″ img_size=”24″ img_close_background_color=”#24a1c0″ close_icon_position=”popup-edge-top-right” content_text_color=”#545454″ header_font_size=”desktop:20px;” header_line_height=”desktop:24px;” content_font_size=”desktop:18px;” content_line_height=”desktop:20px;”]

Deborah K. Mayer, PhD, RN, AOCN, FAANDeborah K. Mayer, PhD, RN, AOCN, FAAN is an advanced practice oncology nurse (ANP-BC) who has consulted with organizations on issues to improve cancer care and has over 40 years of cancer nursing practice, education, research, and management experience. Dr. Mayer earned a PhD from the University of Utah, her MSN from Yale University, her BSN from Excelsior College, her Nurse Practitioner Certificate from the University of Maryland, and her diploma from Pennsylvania Hospital School of Nursing.

Dr. Mayer is past president of the Oncology Nursing Society (ONS), was a member of the National Cancer Institute’s National Cancer Advisory Board (a Presidential appointment) and Board of Scientific Advisors. Dr. Mayer was elected as a fellow of the American Academy of Nursing. She is active in ONS and the American Society of Clinical Oncology (ASCO). She served as the Editor for the ONS’ Clinical Journal of Oncology Nursing (CJON) from 2007-2015 and has published over 150 articles, book chapters and editorials on cancer related issues. She was awarded the ONS Lifetime Achievement Award in 2015 and, in 2016, was appointed as the only nurse to Vice President Biden’s Cancer Moonshot Blue Ribbon Panel. In 2018, she began her role as Interim Director of the Office of Cancer Survivorship with the National Cancer Institute’s Division of Cancer Control and Population Sciences.

Dr. Mayer is on faculty at the School of Nursing at UNC and is the UNC Lineberger Director of Cancer Survivorship. Her program of research focuses on the issues facing cancer survivors and improving cancer care. She has a clinical practice working with breast cancer survivors. As a nurse who works “frontline” with cancer survivors, and as a cancer survivor herself, she brings a unique perspective to her clinical, research and health policy collaborations with cancer survivors and advocates, primary care providers, cancer specialists and researchers.

[/ultimate_modal]

Deborah K. Mayer, PhD, RN, AOCN, FAAN

UNC-Chapel Hill

[ultimate_modal icon_type=”custom” icon_img=”id^9344|url^https://www.carevive.com/wp-content/uploads/2019/04/pic_mary_lou_smith.jpg|caption^null|alt^null|title^pic_mary_lou_smith|description^null” modal_on=”image” btn_img=”id^9344|url^https://www.carevive.com/wp-content/uploads/2019/04/pic_mary_lou_smith.jpg|caption^null|alt^null|title^pic_mary_lou_smith|description^null” modal_size=”medium” modal_style=”overlay-fade” overlay_bg_opacity=”93″ content_bg_color=”#efefef” header_bg_color=”#efefef” modal_border_style=”solid” modal_border_width=”1″ modal_border_color=”#24a1c0″ modal_border_radius=”5″ img_size=”24″ img_close_background_color=”#24a1c0″ close_icon_position=”popup-edge-top-right” content_text_color=”#545454″ header_font_size=”desktop:20px;” header_line_height=”desktop:24px;” content_font_size=”desktop:18px;” content_line_height=”desktop:20px;”]

Mary Lou Smith, JD, MBA, FASCO is a Co-founder of the Research Advocacy Network. She is a two-time breast cancer survivor and an ovarian and colon cancer survivor and serves as Chair of the ECOG-ACRIN Cancer Research Advocates Committee.  She also serves on the National Comprehensive Cancer Network (NCCN) Breast Cancer Screening and Treatment Guidelines Committees.  She is a member of the Mayo Breast SPORE and the NCI Breast Steering Committee’s BOLD Task Force.  Mary Lou serves on the boards of the National Accreditation Program for Breast Centers and Gateway for Cancer Research. She was a community member of the Rush University Medical Center Institutional Review Board for 10 years.  Mary Lou is a past president of Y-ME National Breast Cancer Organization and has served on the Cancer Leadership Council and the National Breast Cancer Coalition’s Board of Directors.

Mary Lou has worked in health care for over 20 years in both hospital administration and consulting.  She was involved in the development of numerous managed care products for the Blue Cross and Blue Shield Association, including a Pediatric Cancer Network.  Mary Lou has a Juris Doctorate with a Health Law Certification and a master’s degree in Business Administration.[/ultimate_modal]

Mary Lou Smith, JD, MBA, FASCO

Research Advocacy Network

[ultimate_modal icon_type=”custom” icon_img=”id^13138|url^https://www.carevive.com/wp-content/uploads/2021/03/hudgens.jpeg|caption^null|alt^Stacie Hudgens CEO Clinical Outcomes Solutions|title^Stacie Hudgens CEO Clinical Outcomes Solutions|description^null” modal_on=”image” btn_img=”id^13138|url^https://www.carevive.com/wp-content/uploads/2021/03/hudgens.jpeg|caption^null|alt^Stacie Hudgens CEO Clinical Outcomes Solutions|title^Stacie Hudgens CEO Clinical Outcomes Solutions|description^null” modal_size=”medium” modal_style=”overlay-fade” overlay_bg_opacity=”93″ content_bg_color=”#efefef” header_bg_color=”#efefef” modal_border_style=”solid” modal_border_width=”1″ modal_border_color=”#24a1c0″ modal_border_radius=”5″ img_size=”24″ img_close_background_color=”#24a1c0″ close_icon_position=”popup-edge-top-right” content_text_color=”#545454″ header_font_size=”desktop:20px;” header_line_height=”desktop:24px;” content_font_size=”desktop:18px;” content_line_height=”desktop:20px;”]Stacie Hudgens - CEO Clinical Outcomes SolutionsStacie Hudgens MSc is Chief Executive Officer and Strategic Lead at Clinical Outcomes Solutions with over 20 years of Pharmaceutical industry, academic and consulting experience and has a specialism in Quantitative Science. She is currently the co-chair of the Psychometric Special Interest Group at ISOQOL.

Stacie has over 20 years of research experience, specializing in research design and statistical and psychometric analysis with extensive US and European Regulatory submissions and presentations including participation on the FDA’s Study Endpoints and Label Development group’s Mixed Methods Panel. She brings 13 years of experience in clinical trials and health and economic outcomes research and 4 years of experience in educational measurement and has developed webinars and symposiums on mixed methods including small sample size psychometric and statistical methodologies.[/ultimate_modal]

Stacie Hudgens MSc

CEO Clinical Outcomes Solutions

Learn more about Carevive

Request a Meeting